Visual electrophysiology and neuropsychology in bipolar disorders: A review on current state and perspectives.

Biomarker Bipolar disorder Cognitive impairment Electroretinogram Neuropsychology Retina Visual Evoked Potential

Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
09 2022
Historique:
received: 29 04 2022
revised: 21 06 2022
accepted: 01 07 2022
pubmed: 7 7 2022
medline: 31 8 2022
entrez: 6 7 2022
Statut: ppublish

Résumé

Bipolar disorder is a lifelong condition. Today, there is a urgent need to find indicators of the disease. Specifically, they could be useful to improve the diagnosis and the early detection, the prognosis, to estimate the treatment response and to create homogeneous subgroups of patients based on similar pathophysiological mechanisms. Here, we assume that visual electrophysiology in combination with a neuropsychological assessment can give additional data to routine practice, especially to precise specific damages and pathophysiological characteristics of these patients. Visual electrophysiology is characterized by an electroretinogram and the delivery of visual evoked potentials, which measure retinal and visual cortical neuronal functioning in response to visual stimulations. This review highlights the interest of visual electrophysiology and neuropsychology performed in isolation and to present the benefits of combining these measures. We will review the results based on these measures in patients with bipolar disorders. Finally, we argue for the use of innovative techniques such as signal processing and artificial intelligence techniques for routine care and precision medicine in bipolar disorders.

Identifiants

pubmed: 35792276
pii: S0149-7634(22)00253-6
doi: 10.1016/j.neubiorev.2022.104764
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104764

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Katelyne Tursini (K)

INSERM U1254, Université de Lorraine, IADI, 54000 Nancy, France; BioSerenity, 20 Rue Berbier du Mets, 75013 Paris, France.

Steven Le Cam (S)

CRAN, CNRS UMR 7039, Université de Lorraine, 54000 Nancy, France.

Raymund Schwan (R)

INSERM U1254, Université de Lorraine, IADI, 54000 Nancy, France; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Faculté de Médecine, Université de Lorraine, Vandœuvre-lès-Nancy, France; Fondation FondaMental, 94000 Créteil, France.

Grégory Gross (G)

INSERM U1254, Université de Lorraine, IADI, 54000 Nancy, France; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Faculté de Médecine, Université de Lorraine, Vandœuvre-lès-Nancy, France; Fondation FondaMental, 94000 Créteil, France.

Karine Angioi-Duprez (K)

Service d'Ophtalmologie, CHRU Nancy, Nancy, France.

Jean-Baptiste Conart (JB)

Service d'Ophtalmologie, CHRU Nancy, Nancy, France.

Irving Remy (I)

BioSerenity, 20 Rue Berbier du Mets, 75013 Paris, France; INSERM U1114, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie, 67000 Strasbourg, France.

Florent Bernardin (F)

Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; INSERM U1114, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie, 67000 Strasbourg, France.

Vincent Laprévote (V)

Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Faculté de Médecine, Université de Lorraine, Vandœuvre-lès-Nancy, France; INSERM U1114, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie, 67000 Strasbourg, France.

Eléa Knobloch (E)

Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Fondation FondaMental, 94000 Créteil, France.

Tiphaine Ricaud (T)

Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Fondation FondaMental, 94000 Créteil, France.

Aline Rahnema (A)

Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Fondation FondaMental, 94000 Créteil, France.

Valérie Louis-Dorr (V)

CRAN, CNRS UMR 7039, Université de Lorraine, 54000 Nancy, France.

Thomas Schwitzer (T)

INSERM U1254, Université de Lorraine, IADI, 54000 Nancy, France; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France; Faculté de Médecine, Université de Lorraine, Vandœuvre-lès-Nancy, France; Fondation FondaMental, 94000 Créteil, France. Electronic address: thomas.schwitzer@univ-lorraine.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH